We are very happy to announce that BRIC Professor Shawn D. Hingtgen, Ph.D. has received the UCRF Innovation Award!

We are very happy to announce that BRIC Professor Shawn D. Hingtgen, Ph.D. has received the UCRF Innovation Award! "Our previous work has demonstrated that neural stem cell (NSC)-based therapies could effectively treat Glioblastoma, however limitations in clinically relevant sources NSCs has prevented the advancement of this approach. We proposed to use cutting-edge technology in cellular reprogramming to develop and assess a novel type of NSC derived from fibroblasts. The ultimate goal is to eventually allow the generation of personalized patient-specific NSC-based therapies for treatment of aggressive and deadly Glioblastoma."